Elevated Liver Enzymes and Genotype I of T. gondii Among Liver Cancer Patients: Evidence of a Potential Link

Nawadir H. Jasim; Ali Al-Waaly

doi:10.31557/apjcp.2026.27.1.361

January 1, 2026Asian Pacific Journal of Cancer PreventionOpen Access

Elevated Liver Enzymes and Genotype I of T. gondii Among Liver Cancer Patients: Evidence of a Potential Link

View Full Paper

Ask AI

Bookmark

Share

Key Points

To investigate the presence of Toxoplasma gondii genotypes in liver cancer patients and their correlation with liver enzyme levels.
Sampled liver cancer patients and a control group
Used nested-PCR and RFLP to analyze the GRA6 gene
Identified genotypes I and II among the samples
Genotype I of T. gondii was predominant in liver cancer patients
Genotype II was predominantly found in the control group

Implication

Genotyping reveals genotype I of T. gondii in liver cancer patients, suggesting a possible connection.

Abstract

This study genotyped Toxoplasma gondii in liver cancer patients using nested-PCR and RFLP targeting the GRA6 gene. Genotype I predominated among liver cancer patients, whereas control Genotypes II was predominance in the control group.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jasim et al. (2026) studied this question.

synapsesocial.com/papers/697460acbb9d90c67120a91d https://doi.org/10.31557/apjcp.2026.27.1.361

View Full Paper

Ask AI

Bookmark

Share

Elevated Liver Enzymes and Genotype I of T. gondii Among Liver Cancer Patients: Evidence of a Potential Link

Key Points

Implication

Abstract

Discussion

Cite This Study

Elevated Liver Enzymes and Genotype I of T. gondii Among Liver Cancer Patients: Evidence of a Potential Link

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading